C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Purchases Shares of 6,970 The Cooper Companies, Inc. (NASDAQ:COO)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 6,970 shares of the medical device company's stock, valued at approximately $691,000.

Several other institutional investors and hedge funds have also recently modified their holdings of COO. State Street Corp increased its stake in shares of Cooper Companies by 1.2% in the 3rd quarter. State Street Corp now owns 8,590,689 shares of the medical device company's stock worth $947,897,000 after acquiring an additional 104,521 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Cooper Companies by 13.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock worth $543,979,000 after acquiring an additional 573,908 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Cooper Companies by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company's stock worth $527,476,000 after acquiring an additional 48,559 shares in the last quarter. Victory Capital Management Inc. increased its stake in shares of Cooper Companies by 23.0% in the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company's stock worth $435,856,000 after acquiring an additional 737,726 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Cooper Companies by 11.9% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company's stock worth $200,665,000 after acquiring an additional 194,118 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

Shares of COO stock traded down $0.21 during trading hours on Friday, reaching $88.48. The company had a trading volume of 1,564,854 shares, compared to its average volume of 1,405,163. The business has a fifty day moving average price of $92.94 and a 200-day moving average price of $99.55. The Cooper Companies, Inc. has a one year low of $84.76 and a one year high of $112.38. The firm has a market cap of $17.66 billion, a PE ratio of 45.37, a price-to-earnings-growth ratio of 2.25 and a beta of 1.00. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.00 by $0.04. The company had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm's revenue was up 9.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.87 earnings per share. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the subject of a number of analyst reports. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research note on Friday, December 6th. Morgan Stanley reduced their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a research note on Friday, December 6th. StockNews.com lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Wednesday, December 11th. Wells Fargo & Company raised their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, December 6th. Finally, Citigroup reduced their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a research note on Friday, December 6th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.